Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Solifenacin Succinate for Treatment of Acute Irritative Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer

NCT02805452 is registered in ClinicalTrials.gov with Center Eugene Marquis as lead sponsor.

NCT NCT02805452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02805452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Solifenacin Succinate for Treatment of Acute Irritative Urinary Toxicity Occurring During Radiotherapy of Prostatic Cancer
Lead sponsor
Center Eugene Marquis
Phase
Phase 3
Overall status
Terminated
Start date
July 31, 2016
Completion date
July 15, 2017
Enrollment
4 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder